Pancreatic cancer chemoradiotherapy

Area of Science:

• Oncology
• Gastrointestinal Oncology
• Radiation Oncology

Background:

• Pancreatic cancer is a highly lethal gastrointestinal malignancy.
• Surgical resection offers the only cure but is feasible for only 15-20% of patients.
• Chemotherapy is the primary treatment modality for most patients.

Purpose of the Study:

• To provide an overview of current and emerging radiotherapeutic strategies for pancreatic cancer.
• To highlight the integration of radiotherapy within multimodal treatment concepts.
• To focus on recent advancements in radiotherapy in conjunction with chemotherapy and surgery.

Main Methods:

• Review of current literature on pancreatic cancer treatment strategies.
• Analysis of the role of induction chemotherapy preceding radiotherapy.
• Discussion of conventional fractionated chemoradiotherapy and stereotactic body radiotherapy.

Main Results:

• Induction chemotherapy followed by radiotherapy is a common approach.
• Conventional chemoradiotherapy is a standard option.
• Stereotactic body radiotherapy is an emerging alternative requiring further clinical investigation.

Conclusions:

• Radiotherapy plays a crucial role in multimodal pancreatic cancer treatment.
• The optimal integration of radiotherapy with chemotherapy and surgery is under continuous investigation.
• Further clinical trials are necessary to validate novel radiotherapy techniques like stereotactic body radiotherapy.